ES2059556T3 - Medicamentos que contienen inhibidores de la sintesis de la progesterona del tipo del trilostano o del epostano y antigestagenos. - Google Patents

Medicamentos que contienen inhibidores de la sintesis de la progesterona del tipo del trilostano o del epostano y antigestagenos.

Info

Publication number
ES2059556T3
ES2059556T3 ES88730135T ES88730135T ES2059556T3 ES 2059556 T3 ES2059556 T3 ES 2059556T3 ES 88730135 T ES88730135 T ES 88730135T ES 88730135 T ES88730135 T ES 88730135T ES 2059556 T3 ES2059556 T3 ES 2059556T3
Authority
ES
Spain
Prior art keywords
trilostan
antigestagens
drugs containing
progesterone synthesis
containing inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88730135T
Other languages
English (en)
Inventor
Walter Dr Elger
Sybille Dr Beier
Beate Kosub
Marianne Fahnrich
Krzysztof Dr Chwalisz
Syed Hamiduddin Dr Hasan
Gordon Oliver Dr Potts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2059556T3 publication Critical patent/ES2059556T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UN MEDICAMENTO QUE CONTIENE UN INHIBIDOR DE LA SINTESIS DE PROGESTERONA (PROH) DEL TIPO DE TRILOSTANO O EPOSTANO Y UN ANTIGESTAGENO (AG) ADECUADO PARA APLICACION EN EL PARTO EN HUMANOS Y ANIMALES PARA LA INTERRUPCION DE LA GRAVIDEZ NORMAL O PATOLOGICA. LA COMBINACION CONFORME A LA INVENCION SIRVE ADEMAS PARA TRATAMIENTO DE TUMORES DEPENDIENTES DE LAS HORMONAS, LA ENDOMETRIOSIS Y LA DISMENORREA.
ES88730135T 1987-06-16 1988-06-14 Medicamentos que contienen inhibidores de la sintesis de la progesterona del tipo del trilostano o del epostano y antigestagenos. Expired - Lifetime ES2059556T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720420 DE3720420A1 (de) 1987-06-16 1987-06-16 Progesteronsynthesehemmer und antigestagene zur geburtseinleitung oder fuer den schwangerschaftsabbruch

Publications (1)

Publication Number Publication Date
ES2059556T3 true ES2059556T3 (es) 1994-11-16

Family

ID=6329981

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88730135T Expired - Lifetime ES2059556T3 (es) 1987-06-16 1988-06-14 Medicamentos que contienen inhibidores de la sintesis de la progesterona del tipo del trilostano o del epostano y antigestagenos.

Country Status (12)

Country Link
EP (1) EP0296097B1 (es)
JP (1) JP2716461B2 (es)
AT (1) ATE94391T1 (es)
AU (1) AU611160B2 (es)
CA (1) CA1318251C (es)
DE (2) DE3720420A1 (es)
DK (1) DK327288A (es)
ES (1) ES2059556T3 (es)
IE (1) IE63453B1 (es)
IL (1) IL86731A (es)
PH (1) PH25728A (es)
ZA (1) ZA884315B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100310276B1 (ko) * 1992-09-25 2002-02-28 데이비드 레슬리 필립 미들톤 맥주라인내의오염물축적방지또는제거방법및장치
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity

Also Published As

Publication number Publication date
AU611160B2 (en) 1991-06-06
DK327288D0 (da) 1988-06-15
JP2716461B2 (ja) 1998-02-18
IE881804L (en) 1988-12-16
DE3884067D1 (de) 1993-10-21
ATE94391T1 (de) 1993-10-15
EP0296097A2 (de) 1988-12-21
CA1318251C (en) 1993-05-25
EP0296097A3 (en) 1990-04-04
ZA884315B (en) 1989-06-28
IL86731A (en) 1992-11-15
AU1775088A (en) 1988-12-22
DK327288A (da) 1988-12-17
IL86731A0 (en) 1988-11-30
PH25728A (en) 1991-10-18
IE63453B1 (en) 1995-04-19
JPS63316725A (ja) 1988-12-26
DE3720420A1 (de) 1988-12-29
EP0296097B1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
DE3850914D1 (de) Gerät für die thermische Therapie von Körpergeweben.
DK196691A (da) Steroid-5-alfa-reduktaseinhibitorer
DK550088A (da) Antigestagen- og antioestrogenvirksomme forbindelser til foedselsindledning og svangerskabsforebyggelse samt til behandling af gynaekologiske forstyrrelser
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
DK645389A (da) Phosphinsyresubstituerede steroider, farmaceutiske midler indeholdende disse samt deres anvendelse
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
FR2591116B1 (fr) Appareil de traitement par hyperthermie.
IT1151774B (it) Procedimento e dispositivo per misurare il tempo di coagulazione del sangue
DE3879620D1 (de) Kompakte vorrichtung zur aussendung von roentgenstrahlen.
FI875039A7 (fi) Terapeuttiset koostumukset eläinlääketieteellistä käyttöä varten.
ES2059556T3 (es) Medicamentos que contienen inhibidores de la sintesis de la progesterona del tipo del trilostano o del epostano y antigestagenos.
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DD135150A1 (de) Einrichtung zur verabreichung von trockenfutter und wasser an schweine
IT1062619B (it) Procedimento ed impianto per la depurazione di-stillativa di 2.5 diosso i ossa 2 fosfolani
IT8767266A0 (it) Dispositivo circuitale per determinare la presenza o la rimozione di oggetti particolarmente strumenti per trattamenti odontoiatrici
NO882066D0 (no) Fremgangsmaate og innretning for aa maale boeyde eller i horisontal retning avboeyde boringer.
DE3872790D1 (de) Geraet zur untersuchung von reissverschlusselementen.
IT1119651B (it) Procedimento e dispositivo per la determinazione del fabbisogno di ossigeno bilogico
DE3879709D1 (de) Platin-arzneimittel.
FR1279011A (fr) Appareil permettant de régler ou d'aider la respiration
IT8221966A0 (it) Impianto elettronico per la determinazione ed il controllo del flusso di anestetico da erogare durante operazioni chirurgiche.
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
FR1281437A (fr) Stérilisateur d'eau, médical
BE754651R (fr) Dispositif d'epuration biologique des eaux

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 296097

Country of ref document: ES